{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:14:05Z","timestamp":1791414845104,"version":"4.3.3"},"reference-count":206,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T00:00:00Z","timestamp":1470182400000},"content-version":"vor","delay-in-days":33,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1111\/bjd.14816","type":"journal-article","created":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T02:33:36Z","timestamp":1470191616000},"page":"23-44","source":"Crossref","is-referenced-by-count":122,"title":["British Association of Dermatologists\u2019 guidelines for the safe and effective prescribing of methotrexate for skin disease 2016"],"prefix":"10.1093","volume":"175","author":[{"given":"R.B.","family":"Warren","sequence":"first","affiliation":[{"name":"The Dermatology Centre Salford Royal NHS Foundation Trust The University of Manchester Manchester Academic Health Science Centre Manchester M6 8HD U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"Weatherhead","sequence":"additional","affiliation":[{"name":"Department of Dermatology Royal Victoria Infirmary Newcastle upon Tyne NE1 4LP U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.H.","family":"Smith","sequence":"additional","affiliation":[{"name":"St John's Institute of Dermatology Guy's and St Thomas NHS Foundation Trust London SE1 9RT U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.S.","family":"Exton","sequence":"additional","affiliation":[{"name":"British Association of Dermatologists Willan House 4 Fitzroy Square London W1T 5HQ U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Mohd Mustapa","sequence":"additional","affiliation":[{"name":"British Association of Dermatologists Willan House 4 Fitzroy Square London W1T 5HQ U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kirby","sequence":"additional","affiliation":[{"name":"St Vincent's University Hospital Elm Park Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.D.","family":"Yesudian","sequence":"additional","affiliation":[{"name":"Glan Clwyd Hospital, Sarn Lane Rhyl LL18 5UJ U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"McHenry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Gibbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.J.","family":"Swale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.","family":"Duarte Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Wakelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ungureanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Hunasehally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.","family":"Brain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,8,3]]},"reference":[{"key":"e_1_2_20_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.09026.x"},{"key":"e_1_2_20_3_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.090449"},{"key":"e_1_2_20_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2008.02976.x"},{"key":"e_1_2_20_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050404"},{"key":"e_1_2_20_6_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130078"},{"key":"e_1_2_20_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08284.x"},{"key":"e_1_2_20_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021359"},{"key":"e_1_2_20_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08315.x"},{"key":"e_1_2_20_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.12.029"},{"key":"e_1_2_20_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10615.x"},{"key":"e_1_2_20_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e6712"},{"key":"e_1_2_20_13_1","unstructured":"National Institute for Health and Care Excellence.CG153 psoriasis: the assessment and management of psoriasis. Available at:https:\/\/www.nice.org.uk\/guidance\/cg153(last accessed 28 June 2016)."},{"key":"e_1_2_20_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket187"},{"key":"e_1_2_20_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.03.024"},{"key":"e_1_2_20_16_1","first-page":"220","article-title":"The efficacy and safety of oral methotrexate in chronic eczema","volume":"19","author":"Syed AR","year":"2009","journal-title":"J Pak Assoc Dermatol"},{"key":"e_1_2_20_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07686.x"},{"key":"e_1_2_20_18_1","first-page":"413","article-title":"Low dose methotrexate therapy is effective in late\u2010onset atopic dermatitis and idiopathic eczema","volume":"10","author":"Zoller L","year":"2008","journal-title":"Isr Med Assoc J"},{"key":"e_1_2_20_19_1","first-page":"155","article-title":"Methotrexate for the treatment of adult atopic dermatitis","volume":"16","author":"Goujon C","year":"2006","journal-title":"Eur J Dermatol"},{"key":"e_1_2_20_20_1","first-page":"60","article-title":"Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial","volume":"17","author":"Baughman RP","year":"2000","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"e_1_2_20_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1977.tb15068.x"},{"key":"e_1_2_20_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/35.4.364"},{"key":"e_1_2_20_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200106)44:6<1351::AID-ART227>3.0.CO;2-I"},{"key":"e_1_2_20_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.7.847"},{"key":"e_1_2_20_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70079-9"},{"key":"e_1_2_20_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70156-8"},{"key":"e_1_2_20_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.11.1506-b"},{"key":"e_1_2_20_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.9.1255"},{"key":"e_1_2_20_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.144.5.612"},{"key":"e_1_2_20_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70227-6"},{"key":"e_1_2_20_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10531.x"},{"key":"e_1_2_20_32_1","first-page":"413","article-title":"Mucous membrane manifestations of pemphigus vulgaris. A 25\u2010year survey of 185 patients treated with corticosteroids or with combination of corticosteroids with methotrexate or heparin","volume":"68","author":"Mashkilleyson N","year":"1988","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_20_33_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1684\/ejd.2011.1611","article-title":"Methotrexate is an effective and safe adjuvant therapy for pemphigus vulgaris","volume":"22","author":"Baum S","year":"2012","journal-title":"Eur J Dermatol"},{"key":"e_1_2_20_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.10.1275"},{"key":"e_1_2_20_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12474"},{"key":"e_1_2_20_36_1","first-page":"1275","article-title":"Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus","volume":"26","author":"Carneiro JR","year":"1999","journal-title":"J Rheumatol"},{"key":"e_1_2_20_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06552.x"},{"key":"e_1_2_20_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002960050058"},{"key":"e_1_2_20_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.01.025"},{"key":"e_1_2_20_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2003.05698.x"},{"key":"e_1_2_20_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(03)01591-3"},{"key":"e_1_2_20_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)80062-4"},{"key":"e_1_2_20_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2010.00998.x"},{"key":"e_1_2_20_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546630802562427"},{"key":"e_1_2_20_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1984.tb04021.x"},{"key":"e_1_2_20_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2010.00734.x"},{"key":"e_1_2_20_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2001.tb00152.x"},{"key":"e_1_2_20_48_1","first-page":"634","article-title":"Methotrexate treatment of pityriasis lichenoides and lymphomatoid papulosis","volume":"23","author":"Lynch PJ","year":"1979","journal-title":"Cutis"},{"key":"e_1_2_20_49_1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1684\/ejd.2010.0958","article-title":"Pityriasis lichenoides chronica induced by infliximab, with response to methotrexate","volume":"20","author":"Lopez\u2010Ferrer A","year":"2010","journal-title":"Eur J Dermatol"},{"key":"e_1_2_20_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1984.tb06640.x"},{"key":"e_1_2_20_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2009.04325.x"},{"key":"e_1_2_20_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70446-9"},{"key":"e_1_2_20_53_1","first-page":"67","article-title":"Severe vulvar scarring in patients with erosive lichen planus: a report of 4 cases","volume":"51","author":"Genadry R","year":"2006","journal-title":"J Reprod Med"},{"key":"e_1_2_20_54_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.4.511"},{"key":"e_1_2_20_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.01.008"},{"key":"e_1_2_20_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2011.04188.x"},{"key":"e_1_2_20_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70212-6"},{"key":"e_1_2_20_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(91)70156-V"},{"key":"e_1_2_20_59_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5070\/D377S3F4BH","article-title":"Erythema elevatum diutinum","volume":"14","author":"Farley Loftus R","year":"2008","journal-title":"Dermatol Online J"},{"key":"e_1_2_20_60_1","first-page":"763","article-title":"Methotrexate in the treatment of vasculitic cutaneous ulceration in rheumatoid arthritis","volume":"82","author":"Williams HC","year":"1989","journal-title":"J R Soc Med"},{"key":"e_1_2_20_61_1","first-page":"326","article-title":"Treatment of pyoderma gangrenosum with methotrexate","volume":"57","author":"Teitel AD","year":"1996","journal-title":"Cutis"},{"key":"e_1_2_20_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02024.x"},{"key":"e_1_2_20_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09923.x"},{"key":"e_1_2_20_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.09.010"},{"key":"e_1_2_20_65_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04330.x"},{"key":"e_1_2_20_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03360.x"},{"key":"e_1_2_20_67_1","doi-asserted-by":"publisher","DOI":"10.3315\/jdcr.2012.1098"},{"key":"e_1_2_20_68_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04298.x"},{"key":"e_1_2_20_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-012-1893-3"},{"key":"e_1_2_20_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.10.001"},{"key":"e_1_2_20_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12314"},{"key":"e_1_2_20_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2010.00634.x"},{"key":"e_1_2_20_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30264"},{"key":"e_1_2_20_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2008.00629.x"},{"key":"e_1_2_20_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1994.tb00602.x"},{"key":"e_1_2_20_76_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.30.3.286"},{"key":"e_1_2_20_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0736-8046.2004.21328.x"},{"key":"e_1_2_20_78_1","first-page":"1570","article-title":"Influence of food on the bioavailability of oral methotrexate in children","volume":"22","author":"Dupuis LL","year":"1995","journal-title":"J Rheumatol"},{"key":"e_1_2_20_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.06.048"},{"key":"e_1_2_20_80_1","unstructured":"British Society for Paediatric and Adolescent Rheumatology.Methotrexate use in paediatric rheumatology. Available at:https:\/\/www.bspar.org.uk\/DocStore\/FileLibrary\/PDFs\/BSPAR%20Guideline%20for%20Methotrexate%202013.pdf(last accessed 28 June 2016)."},{"key":"e_1_2_20_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2008.02907.x"},{"key":"e_1_2_20_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/msc.135"},{"key":"e_1_2_20_83_1","doi-asserted-by":"publisher","DOI":"10.1155\/1996\/213596"},{"key":"e_1_2_20_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.03991.x"},{"key":"e_1_2_20_85_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.094474"},{"key":"e_1_2_20_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20244"},{"key":"e_1_2_20_87_1","unstructured":"UKTIS.Paternal use of methotrexate. Available at:http:\/\/www.medicinesinpregnancy.org\/bumps\/monographs\/PATERNAL-USE-OF-METHOTREXATE\/(last accessed 28 June 2016)."},{"key":"e_1_2_20_88_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1980.01640260091025"},{"key":"e_1_2_20_89_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00383-012-3197-0"},{"key":"e_1_2_20_90_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100600"},{"key":"e_1_2_20_91_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket390"},{"key":"e_1_2_20_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38919"},{"key":"e_1_2_20_93_1","unstructured":"National Institute for Health and Care Excellence.Idiopathic pulmonary fibrosis overview. Available at:http:\/\/pathways.nice.org.uk\/pathways\/idiopathic-pulmonary-fibrosis(last accessed 28 June 2016)."},{"key":"e_1_2_20_94_1","unstructured":"British Thoracic Group.Guideline for non\u2010CF bronchiectasis. Available at:https:\/\/www.brit-thoracic.org.uk\/document-library\/clinical-information\/bronchiectasis\/bts-guideline-for-non-cf-bronchiectasis\/(last accessed 28 June 2016)."},{"key":"e_1_2_20_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(03)00545-0"},{"key":"e_1_2_20_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.03.023"},{"key":"e_1_2_20_97_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-012-1988-2"},{"key":"e_1_2_20_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70175-X"},{"key":"e_1_2_20_99_1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/archderm.1994.01690040051006","article-title":"Zidovudine improves psoriasis in human immunodeficiency virus\u2010positive males","volume":"130","author":"Duvic M","year":"1994","journal-title":"Arch Dermatol"},{"key":"e_1_2_20_100_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199904010-00018"},{"key":"e_1_2_20_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(07)70161-5"},{"key":"e_1_2_20_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.03.047"},{"key":"e_1_2_20_103_1","unstructured":"Department of Health.Contraindications and special considerations: the green book chapter 6. Available at:https:\/\/www.gov.uk\/government\/publications\/contraindications-and-special-considerations-the-green-book-chapter-6(last accessed 28 June 2016)."},{"key":"e_1_2_20_104_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel216a"},{"key":"e_1_2_20_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.11.906"},{"key":"e_1_2_20_106_1","first-page":"18","article-title":"Melanoma screening by means of complete skin exams for all patients in a dermatology practice reduces the thickness of primary melanomas at diagnosis","volume":"7","author":"Chiaravalloti AJ","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_20_107_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07503.x"},{"key":"e_1_2_20_108_1","first-page":"CD000951","article-title":"Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis","volume":"5","author":"Ortiz Z","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_20_109_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.10.1102"},{"key":"e_1_2_20_110_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780360609"},{"key":"e_1_2_20_111_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12941"},{"key":"e_1_2_20_112_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08876.x"},{"key":"e_1_2_20_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.03.027"},{"key":"e_1_2_20_114_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.12120224"},{"key":"e_1_2_20_115_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.12.1515"},{"key":"e_1_2_20_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(05)70365-3"},{"key":"e_1_2_20_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(05)80060-9"},{"key":"e_1_2_20_118_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb02754.x"},{"key":"e_1_2_20_119_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1996.d01-1036.x"},{"key":"e_1_2_20_120_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.03959.x"},{"key":"e_1_2_20_121_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06459.x"},{"key":"e_1_2_20_122_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03932.x"},{"key":"e_1_2_20_123_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12905"},{"key":"e_1_2_20_124_1","doi-asserted-by":"publisher","DOI":"10.1191\/0961203305lu2138oa"},{"key":"e_1_2_20_125_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03389.x"},{"key":"e_1_2_20_126_1","first-page":"CD010542","article-title":"Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease","volume":"1","author":"Pavlov CS","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_20_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.04.043"},{"key":"e_1_2_20_128_1","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/archderm.1989.01670210047006","article-title":"Detection of hepatotoxicity associated with methotrexate therapy for psoriasis","volume":"125","author":"O'Connor GT","year":"1989","journal-title":"Arch Dermatol"},{"key":"e_1_2_20_129_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12782"},{"key":"e_1_2_20_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.09.005"},{"key":"e_1_2_20_131_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/527912"},{"key":"e_1_2_20_132_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2012.07919.x"},{"key":"e_1_2_20_133_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-011-1765-7"},{"key":"e_1_2_20_134_1","first-page":"129","article-title":"Case report: management of methotrexate toxicity in an anephric patient","volume":"5","author":"Langleben A","year":"1982","journal-title":"Clin Invest Med"},{"key":"e_1_2_20_135_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2002.01621.x"},{"key":"e_1_2_20_136_1","first-page":"218","article-title":"Rheumatoid Arthritis Clinical Trial Archive Group. The effect of age and renal function on the efficacy and toxicity of methotrexate in rheumatoid arthritis","volume":"22","year":"1995","journal-title":"J Rheumatol"},{"key":"e_1_2_20_137_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181a61f2d"},{"key":"e_1_2_20_138_1","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.73"},{"key":"e_1_2_20_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.08.001"},{"key":"e_1_2_20_140_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.02122.x"},{"key":"e_1_2_20_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2004.08.020"},{"key":"e_1_2_20_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70069-6"},{"key":"e_1_2_20_143_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.7.812"},{"key":"e_1_2_20_144_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200107)44:7<1515::AID-ART273>3.0.CO;2-7"},{"key":"e_1_2_20_145_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07289.x"},{"key":"e_1_2_20_146_1","first-page":"S38","article-title":"The use of oral ondansetron for severe methotrexate\u2010induced nausea in patients","volume":"147","author":"Walker SL","year":"2002","journal-title":"Br J Dermatol"},{"key":"e_1_2_20_147_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/37.5.590"},{"key":"e_1_2_20_148_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/38.3.280"},{"key":"e_1_2_20_149_1","first-page":"929","article-title":"The use of self\u2010administered subcutaneous methotrexate for the treatment of psoriasis","volume":"13","author":"Chiaravalloti AJ","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_20_150_1","doi-asserted-by":"publisher","DOI":"10.1159\/000249793"},{"key":"e_1_2_20_151_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.11.1425"},{"key":"e_1_2_20_152_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.9.1132"},{"key":"e_1_2_20_153_1","first-page":"270","volume-title":"Tumours of Haematopoietic and Lymphoid Tissues","author":"Harris N","year":"2001"},{"key":"e_1_2_20_154_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1991.tb00582.x"},{"key":"e_1_2_20_155_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090153"},{"key":"e_1_2_20_156_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)91707-1"},{"key":"e_1_2_20_157_1","first-page":"16v23","article-title":"Drug\u2013drug interactions with antirheumatic agents: review of selected clinically important interactions","volume":"22","author":"Stewart CF","year":"1990","journal-title":"J Rheumatol Suppl"},{"key":"e_1_2_20_158_1","first-page":"153","article-title":"Low dose treatment with methotrexate\u2010adverse drug reactions survey","volume":"139","author":"Getov I","year":"2000","journal-title":"Boll Chim Farm"},{"key":"e_1_2_20_159_1","first-page":"2539","article-title":"Celecoxib, a specific COX\u20102 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis","volume":"26","author":"Karim A","year":"1999","journal-title":"J Rheumatol"},{"key":"e_1_2_20_160_1","unstructured":"NICE.NSAIDs \u2013 prescribing issues. Available at:http:\/\/cks.nice.org.uk\/nsaids-prescribing-issues#!scenario(last accessed 28 June 2016)."},{"key":"e_1_2_20_161_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1990.tb02113.x"},{"key":"e_1_2_20_162_1","first-page":"440","article-title":"Methotrexate toxicity in a patient receiving trimethoprim\u2010sulfamethoxazole","volume":"13","author":"Thomas MH","year":"1986","journal-title":"J Rheumatol"},{"key":"e_1_2_20_163_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780290118"},{"key":"e_1_2_20_164_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/37.1.105"},{"key":"e_1_2_20_165_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.295.6601.752"},{"key":"e_1_2_20_166_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200208000-00018"},{"key":"e_1_2_20_167_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199310000-00004"},{"key":"e_1_2_20_168_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.18236"},{"key":"e_1_2_20_169_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200205000-00021"},{"key":"e_1_2_20_170_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei193"},{"key":"e_1_2_20_171_1","first-page":"1129","article-title":"Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis","volume":"20","author":"Sany J","year":"1993","journal-title":"J Rheumatol"},{"key":"e_1_2_20_172_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.3.214"},{"key":"e_1_2_20_173_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2004.12.031"},{"key":"e_1_2_20_174_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2006.01.007"},{"key":"e_1_2_20_175_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.44305"},{"key":"e_1_2_20_176_1","first-page":"2009","article-title":"Deaths following methotrexate overdoses by medical staff","volume":"32","author":"Sinicina I","year":"2005","journal-title":"J Rheumatol"},{"key":"e_1_2_20_177_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.4811972"},{"key":"e_1_2_20_178_1","unstructured":"Toxbase.UNPIS. Available at:http:\/\/www.toxbase.org\/Poisons-Index-A-Z\/M-Products\/Methotrexate(last accessed 30 June 2016)."},{"key":"e_1_2_20_179_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70029-X"},{"key":"e_1_2_20_180_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-0172(95)80009-3"},{"key":"e_1_2_20_181_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.150.1.8025760"},{"key":"e_1_2_20_182_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1992.01680110101015"},{"key":"e_1_2_20_183_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09986.x"},{"key":"e_1_2_20_184_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08865.x"},{"key":"e_1_2_20_185_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08514.x"},{"key":"e_1_2_20_186_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0511"},{"key":"e_1_2_20_187_1","first-page":"539","article-title":"Infliximab treatment for psoriasis in 120 patients on therapy for a minimum of one year: a review","volume":"10","author":"Kamili QU","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_20_188_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10638.x"},{"key":"e_1_2_20_189_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12118"},{"key":"e_1_2_20_190_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket260"},{"key":"e_1_2_20_191_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.024463"},{"key":"e_1_2_20_192_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02976.x"},{"key":"e_1_2_20_193_1","first-page":"116","article-title":"Methotrexate and cyclosporin combined therapy in severe psoriatic arthritis. A pilot study","volume":"186","author":"Mazzanti G","year":"1994","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"e_1_2_20_194_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.01.004"},{"key":"e_1_2_20_195_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)92606-5"},{"key":"e_1_2_20_196_1","first-page":"379","article-title":"Methotrexate and the photodermatitis reactivation reaction: a case report and review of the literature","volume":"66","author":"Khan AJ","year":"2000","journal-title":"Cutis"},{"key":"e_1_2_20_197_1","first-page":"49","article-title":"Delayed reactivation of sunburn by methotrexate: sparing of chronically sun\u2010exposed skin","volume":"39","author":"Westwick TJ","year":"1987","journal-title":"Cutis"},{"key":"e_1_2_20_198_1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/archderm.1981.01650050066027","article-title":"Methotrexate reactivation of sunburn reaction","volume":"117","author":"Korossy KS","year":"1981","journal-title":"Arch Dermatol"},{"key":"e_1_2_20_199_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1965.03860150029006"},{"key":"e_1_2_20_200_1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/archderm.1981.01650100058030","article-title":"Erythema resulting from suberythemogenic doses of ultraviolet radiation and methotrexate","volume":"117","author":"LeVine MJ","year":"1981","journal-title":"Arch Dermatol"},{"key":"e_1_2_20_201_1","doi-asserted-by":"publisher","DOI":"10.1159\/000249755"},{"key":"e_1_2_20_202_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(86)70009-1"},{"key":"e_1_2_20_203_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(84)80007-9"},{"key":"e_1_2_20_204_1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archderm.1983.01650340003007","article-title":"Concurrent methotrexate and etretinate therapy for psoriasis","volume":"119","author":"Adams JD","year":"1983","journal-title":"Arch Dermatol"},{"key":"e_1_2_20_205_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08898.x"},{"key":"e_1_2_20_206_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.16"},{"key":"e_1_2_20_207_1","unstructured":"British Society of Rheumatology.National guidelines for the monitoring of second\u2010line drugs. Available at:http:\/\/www.rheumatology.org.uk\/includes\/documents\/cm_docs\/2009\/m\/monitoring_second_line_drugs.pdf(last accessed 28 June 2016)."}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14816","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14816","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.14816","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjd.14816","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.14816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:22:00Z","timestamp":1676366520000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/175\/1\/23\/6616828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":206,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,8,3]]},"published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1111\/bjd.14816"],"URL":"https:\/\/doi.org\/10.1111\/bjd.14816","archive":["Portico"],"relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}